Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 25, Issue 6, 1996, Pages 302-307

  Sakata, Ken ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

APC gene; H ras gene; microsatellite; oral squamous cell carcinoma; p16 gene; p53 gene; Rb gene

Indexed keywords

EID: 0030199087     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1996.tb00266.x     Document Type: Article

References (49)

1. SANGHVI LD. Epidemiologic and intervention studies. Screening: cancer epidemiology: the Indian scene. J Cancer Res Clin Oncol 1981 99: 1-14.
2. MIYOSHI Y, NAGASE H, ANDO H, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992 1: 229-33.
3. H genes mutated at codon 61. Cell 1986 44: 167-76.
4. FEIG LA, PAN B-T, ROBERTS TM, COOPER GM. Isolation of ras GTP-binding mutants using an in situ colony-binding assay. Proc Natl Acad Sci USA 1986 83: 4607-11.
5. MCGUIR WL, NAYLOR SL. Loss of heterozygosity in breast cancer: cause or ef- feet? J Natl Cancer Inst. 1989 81: 1764-5.
6. UZAWA K, YOSHIDA H, SUZUKI H, et al. Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma. Int J Cancer 1994 58: 814-7.
7. BOYNTON RF, BLOUNT PL, YIN J, et al. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci USA 1992 89: 3385-8.
8. SANO T, TSUJINO T, YOSHIDA K, et al. Frequent loss of heterozygosity on chromosomes 1q, 5q and 17p in human gastric carcinomas. Cancer Res 1991 51: 2926-31.
9. TAMURA G, MAESAWA C, SUZUKI Y, et al. Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. Jpn J Cancer Res 1993 84: 1015-8.
10. D'AMICO D, CARBONE DP, JOHNSON BE, MELTZER SJ, MINNA JD. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in small cell lung cancer. Cancer Res 1992 52: 1996-9.
11. TSUCHIYA E, NAKAMURA Y, WENG S-Y, et al. Allelotype of non-small cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 1992 52: 2478-81.
12. MORITA R, SAITO S, ISHIKAWA J, et al. Common regions of deletion on chromosomes 5q, 6q and l0q in renal cell carcinoma. Cancer Res 1991 51: 5817-20.
13. FUJIMORI M, TOKINO T, HINO O, et al. Allelotype study of primary hepatocellular carcinoma. Cancer Res 1991 51: 89-93.
14. HOLLSTEIN M, SIDRANSKY D, VOGELSTEIN B, HARRIS CC. p53 mutations in human cancers. Science 1991 253: 49-53.
15. BAKER SJ, FEARON ER, NIGRO JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989 244: 217-21.
16. BOYLE JO, HAKIM J, KOCH W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993 53: 4477-80.
17. KAMB A, GRUIS NA, WEAVER-FELDHAUS J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994 264: 436-40.
18. MORI T, MIURA K, AOKI T, NISHIHIRA T, MORI S, NAKAMURA Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994 54: 3396-7.
19. ZHANG S-Y, KLEIN-SZANTO AJP, SAUTER ER, et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 1994 54: 5050-3.
20. SERRANO M, HANNON G, BEACH D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993 366: 704-7.
21. NAWROZ H, RIET P, HRUBAN RH, KOCH W, RUPPERT JM, SIDRANSKY D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994 54: 1152-5.
22. AH-SEE KW, COOKE TG, PICKFORD IR, SOUTAR D, BALMAIN A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 1994 54: 1617-21.
23. FIELD JK, KIARIS H, RISK JM, et al. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer 1995 72: 1180-8.
24. CAIRNS P, MAO L, MERLO A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994 265: 415-6.
25. NEVILLE EM, STEWART M, MYSKOW M, DONNELLY RJ, FIELD JK. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. Oncogene 1995 11: 581-5.
26. TANG A, VARLEY JM, CHAKRABORTY S, MURPHEE AL, FUNG Y-KT. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988 242: 263-6.
27. HOROWITZ JM, PARK S-H, BOGENMANN E, et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 1990 87: 2775-9.
28. HARBOUR JW, LAI SL, WHANG-PENG J, GAZDAR AF, MINNA JD, KAYE FJ. Abnormalities in structure and expression of the human retinoblastoma in SCLC. Science 1988 241: 353-7.
29. STRATTON MR, MOSS S, WARREN W, et al. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene 1990 5: 1297-301.
30. TAMURA G, MAESAWA C, SUZUKI Y, et al Improved detection of loss of heterozygosity at retinoblastoma gene locus in human breast carcinoma. Pathol Int 1994 44: 34-8.
31. BOOKSTEIN R, RIO P, MADREPERLA SA, et al. Promotor deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 1990 87: 7762-6
32. MAESAWA C, TAMURA G, SUZUKI Y, et al. Aberrations of tumor suppressor genes (p53, apc, mcc and Rb) in esophageal squamous-cell carcinoma. Int J Cancer 1994 57: 21-5.
33. YOO GH, XU H-J, BRENNAN JA, et al. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994 54: 4603-6.
34. WHANG-PENG J, KNUTSEN T, DOUGLASS E, et al Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 1984 11: 91-106.
35. ZBAR B, BRAUCH H, TALMADGE C, LINEHAN M. Loss of alleles on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.) 1987; 327: 721-4.
36. BRAUCH H, JOHNSON BE, HOVIS J, et al. Molecular analysis of the short arm of chromosome 3 in small-cell and no small-cell carcinoma of the lung. N Engl J Med 1987; 317: 1109-14.
37. YOKOTA J, TSUKUDA Y, NAKAJIMA T, et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 1989 49: 3598-601.
38. LOTHE R, FOSSA S, STENWIG A, et al. Loss of 3p or 11p is associated with testicular cancer tumours. Genomics 1989 5: 134-8.
39. DEVILEE P, VAN DEN BOECK M, KUIPERS-DUKSHOORN N, KOLLURI R, KHAN P, CORNELISSE C. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 1989 5: 554-60.
40. JONES MH, NAKAMURA Y. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphism. Oncogene 1992 7: 1631-4.
41. OGASAWARA S, MAESAWA C, TAMURA G, SATODATE R. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 1995 55: 891-4.
42. LATIF F, FIVASH M, GLENN G, et al. Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss. Cancer Res 1992 52: 1451-6.
43. EL-NAGGAR AK, MING-SHENG L, WANG G, LUNA MA, GOEPFERT H, BATSAKIS JG. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous cell carcinoma. Cancer 1993 72: 881-6.
44. MAESTRO R, GASPAROTTO D, VUKSAVLJEVIC T, BARZAN L, SULFARO S, BOIOCCHI M. Three discrete regions of deletion in head and neck cancers. Cancer Res 1993 53: 5775-9.
45. WU CL, SLOAN P, READ AP, HARRIS R, THAKKER N. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 1994 54: 6484-8.
46. LATIF F, TORY K, GNARRA J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993 260: 1317-20.
47. CHEN F, KISHIDA T, YAO M, et al. Germ-line mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 1995 5: 66-75.
48. CROSSEY PA, RICHARDS FM, FOSTER K, et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet 1994 3: 1303-8.
49. KIARIS H, SPANDIDOS DA, JONES AS, VAUGHAN ED, FIELD JK. Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck. Br J Cancer 1995 72: 123-8.